Written question asked by Lord Kinnock (Labour) on Monday, 22 June 2026, in the House of Lords. It was due for an answer on Monday, 6 July 2026. It was answered by Baroness Merron (Labour) on Monday, 24 August 2026 on behalf of the Department of Health and Social Care.
Respiratory Diseases: Drugs
- Question
-
To ask His Majesty's Government what assessment they have made of regional variation in England in access to, and take up of, biologic medicines for people with (1) severe asthma, and (2) chronic pulmonary obstructive disease.
- Answer
-
There is currently a total of 21,654 people with severe asthma receiving a biologic for severe asthma in England. The number of people receiving a biologic is based on the number of requests received in the last 12 months, from June 2025 to May 2026, for either new initiation or continuation of asthma biologic treatment. The following table shows a breakdown of the asthma figures by integrated care board (ICB):
Region
Integrated care board
Patient count
East of England
NHS Bedfordshire, Luton and Milton Keynes ICB
236
NHS Cambridgeshire and Peterborough ICB
305
NHS Hertfordshire and West Essex ICB
412
NHS Mid and South Essex ICB
285
NHS Norfolk and Waveney ICB
301
NHS Suffolk and North East Essex ICB
235
London
NHS North Central London ICB
345
NHS North East London ICB
453
NHS North West London ICB
512
NHS South East London ICB
750
NHS South West London ICB
467
Midlands
NHS Birmingham and Solihull ICB
593
NHS Black Country ICB
488
NHS Coventry and Warwickshire ICB
215
NHS Derby and Derbyshire ICB
620
NHS Herefordshire and Worcestershire ICB
247
NHS Leicester, Leicestershire and Rutland ICB
475
NHS Lincolnshire ICB
233
NHS Northamptonshire ICB
256
NHS Nottingham and Nottinghamshire ICB
519
NHS Shropshire, Telford and Wrekin ICB
127
NHS Staffordshire and Stoke-On-Trent ICB
551
North East and Yorkshire
NHS Humber and North Yorkshire ICB
360
NHS North East and North Cumbria ICB
1,351
NHS South Yorkshire ICB
543
NHS West Yorkshire ICB
719
North West
NHS Cheshire and Merseyside ICB
1,434
NHS Greater Manchester ICB
1,225
NHS Lancashire and South Cumbria ICB
670
South East
NHS Buckinghamshire, Oxfordshire and Berkshire West ICB
969
NHS Frimley ICB
172
NHS Hampshire and Isle of Wight ICB
1,271
NHS Kent and Medway ICB
410
NHS Surrey Heartlands ICB
323
NHS Sussex ICB
545
South West
NHS Bath and North East Somerset, Swindon and Wiltshire ICB
366
NHS Bristol, North Somerset and South Gloucestershire ICB
532
NHS Cornwall and The Isles of Scilly ICB
292
NHS Devon ICB
707
NHS Dorset ICB
381
NHS Gloucestershire ICB
356
NHS Somerset ICB
403
In addition, the following table shows a breakdown of the asthma figures by region:Region
Patient count
East of England
1,774
London
2,527
Midlands
4,324
North East and Yorkshire
2,973
North West
3,329
South East
3,690
South West
3,037
Data relating to chronic pulmonary obstructive disease is (COPD) not held. However, through the £10 million Respiratory Transformation Partnership, launched in March, the Government is working with NHS England, the Health Innovation Network, industry, and third sector partners to improve care across asthma and COPD pathways. This includes earlier diagnosis, better long-term management, and pathway redesign to support more consistent uptake of biologic medicines.
Secondary information
- Type
- Written question
- Reference
- HL1163
- Session
- 2026-27
- Grouped for answer
- Yes
- Subjects
- Access Drugs Respiratory diseases
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-08-24 17:16:36 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL1163
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL1163
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL1163